Sarfez Pharmaceuticals, Inc.

Vienna, VA

UEI
YRJBXMC3Y9W6
CAGE
5F4F2
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
  • Subcontinent Asian (Asian-Indian) American Owned
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
10402 Dunn Meadow Rd, Vienna, VA 22182, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract vehicles

Grant awards

Award Agency Obligated Awarded
Extended release torsemide: phase 2 R44DK098856 National Institutes of Health $1,987,476
Extended release torsemide R43DK098856 National Institutes of Health $276,085

Quick answers

Is Sarfez Pharmaceuticals, Inc. registered in SAM.gov?

Yes. Sarfez Pharmaceuticals, Inc.'s SAM.gov registration is active through August 19, 2027.

Which contract vehicles does Sarfez Pharmaceuticals, Inc. hold?

Sarfez Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Sarfez Pharmaceuticals, Inc.'s most recent federal award?

Sarfez Pharmaceuticals, Inc.'s most recent federal grant award is Extended release torsemide: phase 2 (R44DK098856), from National Institutes of Health, on September 27, 2013.

On GovTribe

See Sarfez Pharmaceuticals, Inc.'s full federal record

  • IDV awards
  • Contract vehicles
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login